Association between obesity and pulmonary function impairment
WU Wujun1, LI Xiaoqin1, WANG Yuduo1, HUANG Jingze1, HUANG Yilu2, LU Feng3, WANG Liangyou2
1. Xianju County Center for Disease Control and Prevention, Xianju, Zhejiang 317300, China; 2. Taizhou Center for Disease Control and Prevention (Taizhou Institute of Public Health Supervision), Taizhou, Zhejiang 318000, China; 3. Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang 310051, China
Abstract：Objective To investigate the association between obesity and pulmonary function impairment, so as to provide the evidence for the early identification and intervention of chronic obstructive pulmonary disease (COPD). Methods From 2021 to 2024, permanent residents aged 35 to 75 years in Xianju County, Zhejiang Province, were selected by convenience sampling. Initial screening was conducted using the COPD screening questionnaire, and participants with a score of ≥16 points were included in the field screening. Demographic information and disease history were collected through questionnaire surveys. Height, weight, and waist circumference were measured through physical examinations, and body mass index (BMI) was calculated. Forced expiratory volume in one second (FEV1), forced vital capacity (FVC), and percentage of predicted FEV1 (FEV1%pre) were measured, and FEV1/FVC was calculated. Pulmonary function was classified as normal pulmonary function, preserved ratio impaired spirometry (PRISm), and airflow obstruction. The association between obesity and pulmonary function impairment was analyzed using a multinomial logistic regression model. Results A total of 2 007 individuals were included, with 1 010 (50.32%) males and 997 (49.68%) females. There were 1 210 individuals aged 65 to 75 years, accounting for 60.29%. There were 930 individuals with overweight/obesity, accounting for 46.34%. There were 640 individuals with central obesity, accounting for 31.90%. There were 396, 107, and 534 individuals with general obesity only, central obesity only, and combined obesity, accounting for 19.73%, 5.33%, and 26.61%, respectively. There were 1 563 164, and 280 individuals with normal lung function, PRISm, and airflow obstruction, accounting for 77.88%, 8.17%, and 13.95%, respectively. Multinomial logistic regression analysis showed that overweight/obesity (OR=1.518, 95%CI: 1.082-2.132), central obesity (OR=1.683, 95%CI: 1.196-2.368), central obesity only (OR=2.204, 95%CI: 1.133-4.287), and combined obesity (OR=1.877, 95%CI: 1.257-2.804) were significantly associated with a higher risk of PRISm, while underweight (OR=2.724, 95%CI: 1.358-5.462) was significantly associated with a higher risk of airflow obstruction. Conclusion Obesity, especially central obesity, may increase the risk of PRISm, while underweight may increase the risk of airflow obstruction.
吴武军, 李笑琴, 王宇多, 黄镜泽, 黄依璐, 陆凤, 王良友. 肥胖与肺功能损伤的关联研究[J]. 预防医学, 2026, 38(5): 498-503.
WU Wujun, LI Xiaoqin, WANG Yuduo, HUANG Jingze, HUANG Yilu, LU Feng, WANG Liangyou. Association between obesity and pulmonary function impairment. Preventive Medicine, 2026, 38(5): 498-503.
[1] WANG C,XU J Y,YANG L,et al.Prevalence and risk factors of chronic obstructive pulmonary disease in China(the China Pulmonary Health[CPH]study):a national cross-sectional study[J].Lancet,2018,391(10131):1706-1717. [2] 贾存波,黄可,张春瑜,等.我国18个地市慢性阻塞性肺疾病诊疗能力现状调查[J].中国临床医生杂志,2021,49(6):669-671. [3] 唐娟,曹伟涛,莫泽洵,等.保留比值受损肺功能人群研究进展[J].国际呼吸杂志,2025,45(2):173-177. [4] SHU C C,TSAI M K,LEE J H,et al.Mortality risk in patients with preserved ratio impaired spirometry:assessing the role of physical activity[J].QJM,2024,117(6):436-444. [5] 周泽恺,刘宝胤,聂云韬,等.肥胖对肺功能影响的研究进展[J].中华肥胖与代谢病电子杂志,2024,10(1):58-65. [6] ZHANG H Y,HU Z G,WANG S F,et al.Association of general and abdominal obesity with lung function,FeNO,and blood eosinophils in adult asthmatics:findings from NHANES 2007-2012[J/OL].Front Physiol,2023,14[2026-04-10].http://doi.org/10.3389/fphys.2023.1019123. [7] ZHOU Y M,CHEN S Y,TIAN J,et al.Development and validation of a chronic obstructive pulmonary disease screening questionnaire in China[J].Int J Tuberc Lung Dis,2013,17(12):1645-1651. [8] 中国肥胖问题工作组.中国成人超重和肥胖症预防与控制指南(节录)[J].营养学报,2004,26(1):1-4. [9] Global Initiative for Chronic Obstructive Lung Disease.Global strategy for prevention,diagnosis and management of COPD:2024 report[R/OL].[2026-04-10].https://goldcopd.org/2024-gold-report. [10] WASHIO Y,SAKATA S,FUKUYAMA S,et al.Risks of mortality and airflow limitation in Japanese individuals with preserved ratio impaired spirometry[J].Am J Respir Crit Care Med,2022,206(5):563-572. [11] WIJNANT S R A,DE ROOS E,KAVOUSI M,et al.Trajectory and mortality of preserved ratio impaired spirometry:the Rotterdam Study[J/OL].Eur Respir J,2020,551(1)[2026-04-10].http://doi.org/10.1183/13993003.01217-2019. [12] WAN E S,BALTE P,SCHWARTZ J E,et al.Association between preserved ratio impaired spirometry and clinical outcomes in US adults[J].JAMA,2021,326(22):2287-2298. [13] 尚金梦,邓笑伟.体检人群保留比值受损肺功能的特点及危险因素分析[J].中国全科医学,2024,27(11):1331-1336. [14] SVARTENGREN M,CAI G H,MALINOVSCHI A,et al.The impact of body mass index,central obesity and physical activity on lung function:results of the EpiHealth study[J].ERJ Open Res,2020,6(4):1-10. [15] 赵红英.儿童肥胖和常见呼吸系统疾病的相关性[J].河北医药,2020,42(13):2055-2059. [16] SHANMUGASUNDARAM K,BADE G,SAMPATH M,et al.Effect of obesity on airway mechanics[J].Indian J Endocrinol Metab,2023,27(2):161-166. [17] SKURATOVSKAIA D,KOMAR A,VULF M,et al.IL-6 reduces mitochondrial replication,and IL-6 receptors reduce chronic inflammation in NAFLD and type 2 diabetes[J/OL].Int J Mol Sci,2021,22(4)[2026-04-10].http://doi.org/10.3390/ijms22041774. [18] 张聪,张涵,马经平,等.体重指数与慢性阻塞性肺疾病患病风险的相关性[J].中华健康管理学杂志,2024,18(6):439-445. [19] 罗琴,熊佳,罗杨,等.无明显肺病的成年人群体重不足与肺功能的相关性[J].公共卫生与预防医学,2020,31(2):66-69. [20] 黄露,罗凤鸣.肥胖与慢性阻塞性肺疾病肺功能的相互关系研究进展[J].中华结核和呼吸杂志,2019,42(11):862-864.
